Johnson Matthey PLC (LON:JMAT - Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,433.57 ($19.51) and traded as high as GBX 1,838 ($25.02). Johnson Matthey shares last traded at GBX 1,823 ($24.81), with a volume of 366,038 shares changing hands.
Johnson Matthey Trading Down 0.4%
The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The stock has a market capitalization of £3.05 billion, a P/E ratio of 30.98, a P/E/G ratio of 49,242.50 and a beta of 0.95. The firm's 50 day simple moving average is GBX 1,599.43 and its two-hundred day simple moving average is GBX 1,441.35.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.03) earnings per share for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, analysts forecast that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, insider Liam Condon purchased 30 shares of the firm's stock in a transaction on Wednesday, April 16th. The stock was purchased at an average cost of GBX 1,200 ($16.33) per share, with a total value of £360 ($490.00). Insiders have acquired 62 shares of company stock valued at $84,978 over the last ninety days. Insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Read More
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
